CLINICAL_TRIALS
trial_result
· 2024-03-07
Clinical Trial Update: Double-blind, Randomised Study of A3384 in BAM/BAD [Phase 2]
Summary
A Phase 2 double-blind randomized study of A3384 in bile acid malabsorption has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Albireo | Conditions: Bile Acid Malabsorption | Phase 2 | Status: COMPLETED